PMG Research and MeDiNova Research are now Accellacare.

Accellacare is a global clinical research network increasing patient recruitment and retention with a patient centric approach

The Accellacare feasibility and central process management enables faster study start-up and its dedicated patient engagement team drives identification and recruitment of suitable patients, using an extensive database of patients and targeted campaigns, resulting in higher recruitment levels per site.

Accellacare extends across the globe with 77 active research sites in six countries with expertise in a wide range of therapeutic areas.  It has relationships with 275 Principal Investigators connecting it to 8 million+ patients.

  • 103

    active research sites in 8 countries
  • 275

    Principal investigators
  • 8M+


PMG Research and MeDiNova site networks have conducted almost ten thousand research studies for hundreds of pharmaceutical sponsors and CROs. Together they have more than 40 years combined experience conducting all phases of trials across a comprehensive list of conditions.

Accellacare is a part of Clinical Research Services in ICON plc.